Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report
Open Access
- 1 December 2008
- journal article
- Published by Springer Nature in Cases Journal
- Vol. 1 (1) , 364
Abstract
We report a case of a 53 year old lady recently commenced on etanercept, an anti-TNF (tumour necrosis factor) therapy for rheumatoid arthritis presenting with confusion, pyrexia and an erythematous rash.Keywords
This publication has 11 references indexed in Scilit:
- Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonistsArthritis & Rheumatism, 2007
- Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2006
- Fatal aseptic meningoencephalitis following infliximab treatment for inflammatory bowel disease: Figure 1Gut, 2006
- Meningitis criptocócica tras tratamiento con etanerceptEnfermedades Infecciosas y Microbiología Clínica, 2006
- Infections in patients with rheumatoid arthritis treated with biologic agentsArthritis & Rheumatism, 2005
- Pneumococcal meningitis and etanercept—chance or association?Journal of Infection, 2005
- Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis?Annals of the Rheumatic Diseases, 2004
- Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agentsArthritis & Rheumatism, 2003
- Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trialArthritis & Rheumatism, 2003
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999